- CEO
- Guo Ping Chen
- Full Time Employees
- 1,694
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- Changzhou China
- IPO Date
- Nov 7, 2024
- Business
- Jianerkang Medical Co., Ltd. is a China-based medical technology company primarily engaged in the research, development, manufacturing, and distribution of disposable medical consumables, advanced medical dressings, and disinfection and hygiene products. The company operates across six primary business segments: Surgical Consumables, including connecting tubes, high-negative-pressure drainage systems, suture needle counter boxes, surgical hand-scrub brushes, laryngeal mask airways, and single-use gastric tubes; Wound Care Products, comprising sterile post-operative dressings, transparent adhesive dressings, hydrocolloid dressings, alginate dressings, chitosan wound dressings, and activated carbon fiber dressings; Cleaning and Disinfection Products, featuring medical alcohol wipes and swabs, povidone-iodine prep pads and swabs, chlorhexidine and benzalkonium chloride solutions, hypochlorous acid disinfectants, hydrogen peroxide solutions, and hand sanitizing gels; Infection Control and Protection Supplies, including surgical face masks, medical protective masks, surgical gowns, and isolation garments; Polymer and Auxiliary Medical Devices, encompassing medical ultrasonic coupling gels, disposable oxygen humidification bottles, silicone urinary catheters, and ear irrigation syringes; and Non-Woven Fabrics and Consumer Hygiene Products, which include baby wipes, surface cleaning wipes, medical non-woven roll goods, cosmetic cotton pads, and dry disposable washcloths. Founded in 1999 and headquartered in Changzhou, Jiangsu Province, China, Jianerkang Medical serves healthcare facilities, retail pharmacies, and global medical brand owners. The company distributes its products across domestic medical networks and retail pharmacy chains in China while maintaining extensive international export operations across North America, Europe, Latin America, Asia, Africa, and Oceania through strategic supplier partnerships with global healthcare distributors, including Cardinal Health, Medline Industries, McKesson, and Owens & Minor. In recent developments, Jianerkang Medical completed its initial public offering on the Main Board of the Shanghai Stock Exchange in November 2024 under the ticker 603205, raising approximately RMB 386 million in net proceeds to finance the construction of production facilities for high-end functional medical dressings and non-woven materials, an upgraded research and development center, and integrated enterprise information technology infrastructure. Additionally, the company has undertaken strategic international manufacturing expansion by developing production facilities in Vietnam to optimize its global supply chain, mitigate cross-border trade risks, and accelerate market penetration for high-value medical polymers and advanced wound care solutions.